go back

FLT3 Duplication Amount In Leukemia

Alaska rates for HCPCS 0046U

Used in acute myeloid leukemia to assess a duplication inside the FLT3 gene, a change that affects how the disease behaves. Rather than only reporting whether the duplication is there, it measures how much duplicated sequence is present.

Rates data updated June 2026.

Facilitymedian $1,585 · 10th–90th $407$4,7860%10%10th90th$1,585Professionalmedian $380 · 10th–90th $115$9120%10%20%10th90th$380$100.0$200.0$500.0$1.0K$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,778.28
Median
$3,162.28
Typical High
$5,011.87
Aetna
Setting
Professional
Modifier
Global
Typical Low
$114.82
Median
$380.19
Typical High
$398.11
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,122.02
Median
$1,122.02
Typical High
$1,122.02
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$323.59
Median
$1,380.38
Typical High
$4,786.30
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$134.90
Median
$407.38
Typical High
$1,348.96
Premera BCBS
Setting
Facility
Modifier
Global
Typical Low
$1,412.54
Median
$1,513.56
Typical High
$1,621.81
Premera BCBS
Setting
Professional
Modifier
Global
Typical Low
$407.38
Median
$912.01
Typical High
$912.01
Providence
Setting
Facility
Modifier
Global
Typical Low
$323.59
Median
$1,122.02
Typical High
$1,949.84
Providence
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$147.91
United
Setting
Professional
Modifier
Global
Typical Low
$100.00
Median
$165.96
Typical High
$501.19